Buch
Newer contraceptive methods: long-acting hormones and vaccines : Documents and literature
Frauen-Anstiftung: Newer contraceptive methods: long-acting hormones and vaccines. Frauen-Anstiftug ; Introdutory information packet ; 4, 1989. (BPI FK 3)
- Inventarnummer
-
BPI FK 3
- Umfang
-
207
- Sprache
-
Deutsch
- Bezug (was)
-
Gesundheit
Asien
- Bezug (wo)
-
Indien
Bangladesh
- Bezug (wann)
-
1989
- Beteiligte Personen und Organisationen
-
Frauen-Anstiftung
Frauen-Anstiftung [Hrsg.]
Frauen-Anstiftung
- Erschienen
-
Frauen-Anstiftung
- Geliefert über
- Rechteinformation
-
ausZeiten, Bildung, Information, Forschung und Kommunikation für Frauen e.V. - Bibliothek
- Letzte Aktualisierung
-
03.02.2023, 09:26 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ausZeiten, Bildung, Information, Forschung und Kommunikation für Frauen e.V. - Bibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ausZeiten, Bildung, Information, Forschung und Kommunikation für Frauen e.V. - Bibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Buch
Beteiligte
- Frauen-Anstiftung
- Frauen-Anstiftung [Hrsg.]
Entstanden
- Frauen-Anstiftung
Ähnliche Objekte (12)
Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe
Long-Acting Reversible Contraception
Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study
![Long-acting contraceptive delivery systems : [proceedings of an International Workshop on Long-Acting Contraceptive Delivery Systems, May 31 - June 3, 1983, New Orleans, Louisiana, sponsored by the Program for Applied Research on Fertility Regulation, Northwestern University, Chicago, Illinois]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Long-acting contraceptive delivery systems : [proceedings of an International Workshop on Long-Acting Contraceptive Delivery Systems, May 31 - June 3, 1983, New Orleans, Louisiana, sponsored by the Program for Applied Research on Fertility Regulation, Northwestern University, Chicago, Illinois]
Creation of a long-acting nanoformulated dolutegravir
Women’s empowerment indicators and short- and long-acting contraceptive method use: evidence from DHS from 11 countries
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Intention to use long-acting and permanent contraceptive methods and associated factors in health institutions of Aksum Town, North Ethiopia
Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe
Long-Acting Reversible Contraception
Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study
Long-acting contraceptive delivery systems : [proceedings of an International Workshop on Long-Acting Contraceptive Delivery Systems, May 31 - June 3, 1983, New Orleans, Louisiana, sponsored by the Program for Applied Research on Fertility Regulation, Northwestern University, Chicago, Illinois]
Creation of a long-acting nanoformulated dolutegravir
Women’s empowerment indicators and short- and long-acting contraceptive method use: evidence from DHS from 11 countries
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Intention to use long-acting and permanent contraceptive methods and associated factors in health institutions of Aksum Town, North Ethiopia
Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe
Long-Acting Reversible Contraception
Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study
Long-acting contraceptive delivery systems : [proceedings of an International Workshop on Long-Acting Contraceptive Delivery Systems, May 31 - June 3, 1983, New Orleans, Louisiana, sponsored by the Program for Applied Research on Fertility Regulation, Northwestern University, Chicago, Illinois]
Creation of a long-acting nanoformulated dolutegravir
Women’s empowerment indicators and short- and long-acting contraceptive method use: evidence from DHS from 11 countries
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis